NO890644L - Fremgangsmaate for fremstilling av nye aspartat-transcarbamylase-inhibitorer. - Google Patents

Fremgangsmaate for fremstilling av nye aspartat-transcarbamylase-inhibitorer.

Info

Publication number
NO890644L
NO890644L NO89890644A NO890644A NO890644L NO 890644 L NO890644 L NO 890644L NO 89890644 A NO89890644 A NO 89890644A NO 890644 A NO890644 A NO 890644A NO 890644 L NO890644 L NO 890644L
Authority
NO
Norway
Prior art keywords
aspartat
procedure
preparation
new
transcarbamylase
Prior art date
Application number
NO89890644A
Other languages
English (en)
Norwegian (no)
Other versions
NO890644D0 (no
Inventor
Serge Halazy
Charles Danzin
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO890644D0 publication Critical patent/NO890644D0/no
Publication of NO890644L publication Critical patent/NO890644L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3808—Acyclic saturated acids which can have further substituents on alkyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO89890644A 1988-02-16 1989-02-15 Fremgangsmaate for fremstilling av nye aspartat-transcarbamylase-inhibitorer. NO890644L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP88400348A EP0328834A1 (fr) 1988-02-16 1988-02-16 Inhibiteurs d'aspartate transcarbamylase

Publications (2)

Publication Number Publication Date
NO890644D0 NO890644D0 (no) 1989-02-15
NO890644L true NO890644L (no) 1989-08-17

Family

ID=8200350

Family Applications (1)

Application Number Title Priority Date Filing Date
NO89890644A NO890644L (no) 1988-02-16 1989-02-15 Fremgangsmaate for fremstilling av nye aspartat-transcarbamylase-inhibitorer.

Country Status (12)

Country Link
EP (2) EP0328834A1 (fr)
JP (1) JPH02149589A (fr)
CN (1) CN1036207A (fr)
AU (1) AU609942B2 (fr)
DK (1) DK69489A (fr)
FI (1) FI890695A (fr)
HU (1) HUT49142A (fr)
IL (1) IL89287A (fr)
NO (1) NO890644L (fr)
NZ (1) NZ227978A (fr)
PT (1) PT89718B (fr)
ZA (1) ZA891078B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0465297B1 (fr) * 1990-07-04 1996-01-31 Merrell Dow Pharmaceuticals Inc. Dérivés d'acides 9-purinyl phosphoniques
US5095007A (en) * 1990-10-24 1992-03-10 Ahluwalia Gurpreet S Alteration of rate and character of hair growth
GB9200826D0 (en) * 1992-01-15 1992-03-11 Celltech Ltd Peptidyl derivatives
JP7037069B2 (ja) * 2016-09-14 2022-03-16 ダイキン工業株式会社 分枝含フッ素化合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3425701A1 (de) * 1984-07-12 1986-01-16 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von chlorierten phosphorylmethylcarbonyl-derivaten und neue zwischenprodukte zu ihrer herstellung
FR2590259B1 (fr) * 1985-11-20 1989-05-12 Roussel Uclaf Procede de preparation de derives fluores de l'acide phosphonique, et produits obtenus par la mise en oeuvre de ce procede
FR2596393B1 (fr) * 1986-04-01 1988-06-03 Sanofi Sa Derives de l'acide hydroxy-3 dihydroxyoxophosphorio-4 butanoique, leur procede de preparation, leur application comme medicament et les compositions les renfermant

Also Published As

Publication number Publication date
NZ227978A (en) 1990-10-26
PT89718A (pt) 1989-10-04
EP0331550A1 (fr) 1989-09-06
DK69489D0 (da) 1989-02-15
JPH02149589A (ja) 1990-06-08
ZA891078B (en) 1989-10-25
PT89718B (pt) 1994-03-31
EP0328834A1 (fr) 1989-08-23
IL89287A (en) 1993-02-21
AU2990489A (en) 1989-08-17
HUT49142A (en) 1989-08-28
AU609942B2 (en) 1991-05-09
FI890695A0 (fi) 1989-02-14
NO890644D0 (no) 1989-02-15
FI890695A (fi) 1989-08-17
CN1036207A (zh) 1989-10-11
DK69489A (da) 1989-08-17
IL89287A0 (en) 1989-09-10

Similar Documents

Publication Publication Date Title
NO891951D0 (no) Fremgangsmaate for fremstilling av nye hydroksamat-derivater.
NO892230D0 (no) Fremgangsmaate for fremstilling av nye alfa-glucosidaseinhibitorer.
NO903314L (no) Fremgangsmaate for fremstilling av nye peptidaseinhibitorer
NO892136L (no) Fremgangsmaate for fremstilling av nye peptider.
NO873091L (no) Fremgangsmaate for fremstilling av nye benzimidazolderivater.
NO902776D0 (no) Fremgangsmaate for fremstilling av nye acetylcholinesterase-inhibitorer.
NO904059D0 (no) Fremgangsmaate for fremstilling av nye substituerte isokinoliner.
NO892543L (no) Fremgangsmaate for fremstilling av nye neplanocinderivater.
NO901813D0 (no) Fremgangsmaate for fremstilling av nye tieno-triazolo-diazepin-derivater.
NO913391D0 (no) Fremgangsmaate for fremstilling av nye hetrazepinoide syreamider.
NO904372L (no) Fremgangsmaate for fremstilling av nye alfa-glucosidaseinhibitorer.
NO880851D0 (no) Fremgangsmaate for fremstilling av nye renin-inhibitorer.
NO892977D0 (no) Fremgangsmaate for fremstilling av nye s-adenosylmethionin-derivater.
NO904069L (no) Fremgangsmaate for fremstilling av nye alkanofenoner.
NO891381D0 (no) Fremgangsmaate for fremstilling av nye fluorfosfonatnukleotidderivater.
NO911118D0 (no) Fremgangsmaate for fremstilling av nye 8-sulfamylmethylen-2-amino-tetraliner.
NO890644D0 (no) Fremgangsmaate for fremstilling av nye aspartat-transcarbamylase-inhibitorer.
NO872393L (no) Fremgangsmaate for fremstilling av nye aralkylimidazolderivater.
NO854577L (no) Fremgangsmaate for fremstilling av nye tienopyridinderivater.
NO169590C (no) Analogifremgangsmaate for fremstilling av nye, terapeutiskaktive sialosylglycerider
NO901422D0 (no) Fremgangsmaate for fremstilling av alfa-glucosidase-inhibitorer.
NO871721L (no) Fremgangsmaate for fremstilling av nye ergolenderivater.
NO893006D0 (no) Fremgangsmaate for fremstilling av nye allylaminoetylazoler
NO894967L (no) Fremgangsmaate for fremstilling av nye thrombolytiske proteiner.
NO902293D0 (no) Fremgangsmaate for fremstilling av nye tiazepinderivater.